天津利安隆新材料股份有限公司 1.报告期内，公司不存在控股股东及其他关联方非经营性占用上市公司资金 的情况； 独立董事关于第四届董事会第九次会议相关事项的独立意见 根据《上市公司独立董事规则》、《独立董事工作制度》、《深圳证券交易 所创业板股票上市规则》及《公司章程》等有关规定，我们作为天津利安隆新材 料股份有限公司（以下简称"公司"）第四届董事会独立董事，本着认真、负责 的态度，基于独立、审慎、客观的立场，审阅了公司董事会提供的关于公司第四 届董事会第九次会议相关议案，经过仔细的分析和研究，发表独立意见如下： 一、关于公司 2023 年半年度募集资金存放与实际使用情况的独立意见 我们根据《公司法》、《证券法》、《规范运作》等法律、法规和规范性文 件及公司《募集资金管理办法》的要求对公司 2023 年半年度募集资金存放和使 用情况进行了检查，经核查我们认为：2023 年上半年，公司已按照相关规定对募 集资金进行了专户存储和使用，公司募集资金的存放和使用符合中国证监会、深 圳证券交易所关于上市公司募集资金存放和使用的相关规定，不存在募集资金存 放和使用违规的情形。公司编制的《2023 年半年度募集资金存放与实际 ...

天津利安隆新材料股份有限公司 独立董事关于第四届董事会第九次会议相关事项的事前认可 何勇军： 拟提交公司董事会审议的《关于变更募集资金专用账户后重新签订募集资 金三方监管协议的议案》中，公司决定变更募集资金专用账户后重新签订募集 资金三方监管协议，实行专户专储管理、专款专用，符合法律、法规的规定， 有利于募集资金的管理和使用，提高了募集资金使用的效率，保障了公司及股 东的利益。 综上，我们认为，公司第四届董事会第九次会议审议的相关议案符合有关 法律、法规、规范性文件及《公司章程》的规定，不存在损害公司利益及全体 股东特别是中小股东利益的情形。我们同意将上述议案提交公司第四届董事会 第九次会议审议。 （以下无正文） （本页无正文，为天津利安隆新材料股份有限公司《独立董事关于第四届董事会 第九次会议相关事项的事前认可》的签字页） 独立董事： 韦利行： 侯为满： 李红梅： 根据《上市公司独立董事规则》、《深圳证券交易所创业板股票上市规则》 等规章、规范性文件及《公司章程》的有关规定，我们作为上市公司的独立董 事，基于独立判断的立场，已于会前获得并审阅了拟提交公司第四届董事会第 九次会议审议的相关议案和文件，经认真审 ...

天津利安隆新材料股份有限公司 离任董监高持股及减持承诺事项的说明 天津利安隆新材料股份有限公司（以下简称"公司"）于 2023 年 8 月 23 日 召开第四届董事会第九次会议，审议通过了《关于聘任财务总监的议案》。公司 董事、财务总监、副总裁、董事会秘书谢金桃女士因工作调整原因申请辞去公司 财务总监职务，辞职后在公司仍担任董事、副总裁、董事会秘书职务。 谢金桃女士原定任期为 2022 年 7 月 13 日至 2025 年 7 月 12 日。截至本公 告披露日，谢金桃女士持有公司股份 2,091,317 股，占公司总股本的比例为 0.9107%，不存在应当履行而未履行的承诺事项。谢金桃女士辞职后将继续遵守 《上市公司股东、董监高减持股份的若干规定》、《深圳证券交易所上市公司股 东及董事、监事、高级管理人员减持股份实施细则》等相关法律法规的规定。 特此公告。 天津利安隆新材料股份有限公司 董事会 2023 年 8 月 25 日 ...

Financial Performance - The company's revenue for Q1 2023 was CNY 1,186,169,426.28, representing a 17.37% increase compared to CNY 1,010,659,817.18 in the same period last year[4] - Net profit attributable to shareholders decreased by 34.31% to CNY 82,930,313.98 from CNY 126,246,491.44 year-on-year[4] - Basic and diluted earnings per share fell by 41.34% to CNY 0.3612 from CNY 0.6158 in the same quarter last year[4] - The net profit for Q1 2023 was CNY 83,429,849.36, down from CNY 125,218,058.20 in Q1 2022, indicating a decline of about 33.5%[18] - The total comprehensive income for Q1 2023 was CNY 80,385,652.66, compared to CNY 124,058,493.71 in Q1 2022, reflecting a decline of approximately 35.2%[18] Cash Flow and Operating Activities - The net cash flow from operating activities was negative at CNY -107,966,108.30, a decline of 388.98% compared to CNY 37,360,730.31 in the previous year[4] - The company reported a significant decrease in cash received from operating activities, down 91.58% to CNY 8,211,015.11 from CNY 97,559,829.24 in the previous year[9] - Cash flow from operating activities showed a net outflow of CNY 107,966,108.30 in Q1 2023, contrasting with a net inflow of CNY 37,360,730.31 in Q1 2022[21] Assets and Liabilities - Total assets increased by 4.99% to CNY 7,960,900,331.64 from CNY 7,582,823,208.24 at the end of the previous year[4] - Total liabilities increased to CNY 3,944,500,681.35 from CNY 3,654,719,137.22, reflecting a rise of 7.9%[14] - The company's equity attributable to shareholders reached CNY 3,899,754,976.50, compared to CNY 3,816,619,813.32 at the beginning of the year, an increase of 2.2%[14] Operating Costs and Expenses - The company's operating costs rose by 30.73% to CNY 960,441,278.13, primarily due to increased sales volume[7] - The total operating costs for Q1 2023 were CNY 1,086,351,745.71, an increase from CNY 857,680,232.00 in Q1 2022, representing a growth of approximately 26.6%[17] - The R&D expenses for Q1 2023 were CNY 33,488,544.54, a decrease from CNY 40,033,425.12 in Q1 2022, indicating a reduction of approximately 16.4%[17] - The company incurred a financial expense of CNY 11,058,201.34 in Q1 2023, down from CNY 12,643,479.77 in Q1 2022, showing a decrease of about 12.5%[17] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 10,338[10] Future Outlook - The company plans to continue expanding its market presence and invest in new product development to drive future growth[12]

天津利安隆新材料股份有限公司投资者关系活动记录表 编号：20230414 投资者关系活动类 别 □特定对象调研 分析师会议 □媒体采访 □√ 业绩说明会 □新闻发布会 □路演活动 □现场参观 □一对一沟通 □其他 参与单位名称及人 员姓名 投资者网上提问 时间 2023 年 4 月 12 日 15:00-17:00 地点 公司通过全景网 "投资者关系互动平台"（http://ir.p5w.net） 采用网络远程的方式召开业绩说明会 上市公司接待人员 1. 董事长、总裁：李海平先生 2. 董事、副总裁：孙春光先生 3. 董事、副总裁、财务总监兼董事会秘书：谢金桃女士 4. 独立董事：何勇军先生 投资者关系活动主 要内容介绍 投资者提出的问题及公司回复情况： 1、您好，请问利安隆科润，2022 年度净利润大幅下降 的原因？是下半年紫外线吸收剂竞争激烈，毛利率下降造 成吗。公司一直有科润二期的规划，请问今年还会实施吗？ 珠海基地的产能利用率今年计划达到什么水平？谢谢！ 答：您好！科润净利润下降的原因是毛利率下降导致 的。科润二期规划的实施请关注公司的公告。珠海产能利 用率能达到什么水平和国内经济复苏密切相关。感谢您 ...

Financial Performance - The company reported a cash dividend of 3.44 RMB per 10 shares for all shareholders, based on a total of 229,619,667 shares[3]. - The company's operating revenue for 2022 was ¥4,842,783,545.67, representing a 40.59% increase compared to ¥3,444,636,127.78 in 2021[19]. - The net profit attributable to shareholders for 2022 was ¥525,718,826.08, a 25.89% increase from ¥417,594,673.31 in 2021[19]. - The net cash flow from operating activities reached ¥513,847,807.57, marking a significant increase of 64.63% from ¥312,125,695.41 in 2021[19]. - The total assets at the end of 2022 amounted to ¥7,582,823,208.24, a 35.95% increase from ¥5,577,662,386.18 at the end of 2021[19]. - The company achieved a compound annual growth rate (CAGR) of 27.52% in sales revenue from 2011 to 2022[31]. - The compound annual growth rate (CAGR) for net profit attributable to shareholders from 2011 to 2022 was 31.47%[31]. - The company reported a basic earnings per share of ¥2.3965 for 2022, up 17.65% from ¥2.0369 in 2021[19]. - The company achieved a revenue of 4.843 billion yuan in 2022, representing a year-on-year growth of 40.59%[74]. - The net profit attributable to shareholders was 526 million yuan, an increase of 25.89% compared to the previous year[74]. Market Expansion and Strategy - The company aims to expand its market presence and enhance its supply chain management capabilities[10]. - The company is focused on developing new products and technologies in the polymer materials sector, particularly in chemical additives[11]. - The company aims to be a global leader in polymer material anti-aging technology, which is essential for extending the lifespan of materials and reducing carbon emissions[32]. - The company plans to increase its market presence in the rapidly growing China and Asia-Pacific markets, as well as in the Middle East, Eastern Europe, Africa, and South America[74]. - The company is actively pursuing new technologies and product developments to maintain its market position and drive future growth[55]. - The company is committed to breaking the foreign monopoly in the gas engine oil market, which is currently dominated by Chevron[103]. - The company is focusing on expanding its market presence through strategic partnerships and potential acquisitions in the chemical sector[137]. Research and Development - The company has established a life sciences division, focusing on two key areas: biological building blocks and synthetic biology, aiming to create internationally leading technologies and products[46]. - The company has built a research and operation team of about 50 people in the life sciences sector, with several new products expected to enter trial production soon[49]. - The company has developed multiple patented production technologies for antioxidants, including RIANOXMD-1024 and RIANOX1010, with several patents filed under ZL and CN numbers[52]. - The company is actively pursuing the industrialization of nucleic acid drug monomers and technologies, positioning itself for future growth in the pharmaceutical sector[48]. - The company is focusing on new material technology research and development, aiming to enhance its product offerings and market competitiveness[137]. - The company has a research team of over 300 people and is collaborating with top universities to innovate in polymer materials and life sciences[148]. Acquisitions and Partnerships - The company completed the acquisition of Jinzhou Kangtai, adding lubricating oil additives to its main business, which is expected to drive sustained high growth[39]. - The company has integrated Jinzhou Kangtai into its system as a subsidiary since May 2022, focusing on achieving expected synergies and operational integration[159]. - The company invested in Jinzhou Kangtai Lubricant Additive Co., Ltd. through share issuance and cash payment, aiming to expand market supply and customer assurance capabilities in the lubricant additive sector[140]. - The establishment of the "Lubricating Oil Industry Innovation Alliance" aims to address the self-controllable supply chain challenges in China's lubricating oil sector, with significant strategic opportunities expected from the upcoming release of diesel and gasoline engine lubricating oil standards[44]. Environmental and Safety Management - The company has a comprehensive EHS management system to improve safety, environmental, and health performance[10]. - The company is committed to green development, aligning with carbon neutrality policies and investing in energy-saving technologies[81]. - The company has a strong emphasis on environmental protection through the development of high-efficiency and eco-friendly antioxidant products[52]. - The company is committed to contributing to carbon neutrality goals through innovative recycling solutions[101]. Governance and Management - The company has a governance structure in place with a board of directors and supervisory board, ensuring compliance with corporate governance standards[192]. - The company has established a transparent performance evaluation and incentive mechanism for senior management[180]. - The company has a diverse board composition, including independent directors, to ensure a balanced decision-making process[192]. - The company has maintained a stable shareholding structure, with no significant changes in the number of shares held by directors and senior management during the reporting period[192]. - The company respects and protects the legitimate rights and interests of stakeholders, balancing the interests of customers, employees, shareholders, and society[181]. Financial Management - The company has implemented measures to manage accounts receivable risks, including performance assessments for marketing personnel and credit control based on customer classification[158]. - The company is committed to enhancing financial and internal control management post-acquisition to mitigate risks[159]. - The company reported a significant increase in cash received from investment to CNY 423.90 million in 2022 from CNY 3 million in 2021[104]. - The company has ongoing research and development efforts in new materials, with a focus on expanding its product offerings in the chemical sector[115]. Future Outlook - The company plans to launch three new products in 2023, targeting a market expansion of 20% in the new segments[166]. - Future guidance estimates a revenue growth of 10-15% for 2023, driven by new product launches and market expansion efforts[165]. - The company is exploring potential acquisitions to enhance its product portfolio and market reach, with a budget of 500 million RMB allocated for this purpose[173]. - The company aims to enhance its product offerings in response to stricter emission regulations and the decreasing availability of fossil resources[102].

Financial Performance - The company's operating revenue for 2022 was ¥4,842,783,545.67, representing a 40.59% increase compared to ¥3,444,636,127.78 in 2021[19]. - The net profit attributable to shareholders for 2022 was ¥525,718,826.08, a 25.89% increase from ¥417,594,673.31 in 2021[19]. - The net cash flow from operating activities reached ¥513,847,807.57, marking a significant increase of 64.63% from ¥312,125,695.41 in 2021[19]. - The total assets at the end of 2022 amounted to ¥7,582,823,208.24, a 35.95% increase from ¥5,577,662,386.18 at the end of 2021[19]. - The company achieved a compound annual growth rate (CAGR) of 27.52% in sales revenue from 2011 to 2022[31]. - The compound annual growth rate (CAGR) for net profit attributable to shareholders from 2011 to 2022 was 31.47%[31]. - The company reported a basic earnings per share of ¥2.3965 for 2022, reflecting a 17.65% increase from ¥2.0369 in 2021[19]. - The company achieved a revenue of 4.843 billion yuan in 2022, representing a year-on-year growth of 40.59%[74]. - The net profit attributable to shareholders was 526 million yuan, an increase of 25.89% compared to the previous year[74]. Market Expansion and Strategy - The company aims to enhance its market presence through new product development and technological advancements in polymer materials[11]. - The company is focused on expanding its user base and improving customer engagement through innovative solutions in chemical additives[11]. - The company is exploring potential mergers and acquisitions to accelerate growth and enhance its competitive edge in the market[11]. - The company has set ambitious performance targets for the upcoming fiscal year, aiming for a significant increase in revenue and market share[11]. - The company is actively investing in research and development to innovate and improve its product offerings in the high polymer materials sector[11]. - The company is strategically positioned to leverage its technological advancements and production capabilities to capture a larger market share in the chemical industry[53]. - The company is expanding its market presence in high-growth regions such as China, the Asia-Pacific, the Middle East, Eastern Europe, Africa, and South America[74]. - The company plans to continue expanding its market presence and product offerings, particularly in the lubricant additives sector[94]. - The company aims to enhance its supply assurance capabilities and establish a leading position in the global industry[140]. Research and Development - The company is committed to maintaining a robust pipeline of new product developments and technological advancements in the antioxidant sector[52]. - The company has developed multiple patented production technologies for antioxidants, including RIANOXMD-1024 and RIANOX1010, with several patents filed under ZL201010514830.8 and ZL201310373588.0[52]. - The company has established a life sciences division, focusing on two key areas: biological building blocks and synthetic biology, aiming to develop internationally competitive technologies and products[46]. - The company has built a research and operation team of about 50 people in the life sciences sector, with plans for new products to be trial-produced and launched soon[49]. - The company is focused on the innovation of high-performance UV stabilizers, with several patented technologies for products like UV-326 and UV-360[52]. - The company is actively developing new technologies and products, including a boron-based dispersant and various antioxidant formulations for lubricants[53]. - The company has a strong focus on R&D, with multiple patents filed for new materials and production processes, enhancing its competitive edge in the market[53]. - The R&D team consists of over 300 members, with new research institutes established to enhance innovation in polymer materials and life sciences[147]. Environmental and Social Responsibility - The company emphasizes its commitment to environmental and social responsibility in its operational strategies[11]. - The company has a strong focus on environmental protection in its production processes, as evidenced by its development of eco-friendly technologies[52]. - The company has committed to green development in response to carbon neutrality policies, focusing on energy efficiency and technological upgrades[81]. - The company is addressing the challenges of using complex and degraded PCR recycled plastics through innovative formulations[101]. Governance and Management - The board of directors consists of 11 members, including 4 independent directors, complying with legal and regulatory requirements[176]. - The company has a supervisory board with 3 members, including 1 employee representative, ensuring oversight of the board and management[178]. - The company has implemented a transparent performance evaluation and incentive mechanism for senior management, ensuring compliance with legal regulations[179]. - The company maintains financial independence with a dedicated finance department and independent accounting system, ensuring autonomous financial decision-making[187]. - The management team has a clear strategic vision for sustainable development, leveraging extensive industry experience and a robust operational capability[58]. Financial Management and Investments - The company has a self-funded construction rate of 95% for its projects, indicating strong financial management[120]. - The company is committed to maintaining a high utilization rate of its raised funds, with 0% reported as idle[125]. - The total amount of raised funds is RMB 41.7 million, with no changes reported in the investment projects during the reporting period[131]. - The company has made strategic investments in new projects, although specific details on the projects were not provided[113]. - The company is focusing on technological advancements in new materials, which is expected to drive future growth[198]. Customer and Market Insights - The company has over 3,000 customers globally, with a marketing network covering more than 20 countries and regions, enhancing its brand influence and reputation[67]. - User data indicates that the production capacity for hydrogen reached 2 million m³/a, highlighting the company's focus on sustainable materials[135]. - User data showed an increase in active users by 20% year-on-year, reaching 500,000 users by the end of 2022[165]. - The company plans to launch three new products in 2023, targeting a market expansion of 25% in the new segments[164]. Future Outlook - Future guidance indicates a continued upward trend in revenue and profitability, driven by strategic investments and market expansion efforts[136]. - The company plans to enhance its digital marketing efforts, aiming for a 50% increase in online sales channels by the end of 2023[174]. - The company aims to enhance its antioxidant capacity utilization and implement technological upgrades across production bases in 2023[144]. - The company is committed to achieving the first annual profit for the life sciences division by 2023, with plans for industrial-scale production of key products[152].

证券代码：300596 证券简称：利安隆 公告编号：2023-031 天津利安隆新材料股份有限公司 关于举行 2022 年度网上业绩说明会的公告 天津利安隆新材料股份有限公司 董事会 出席本次说明会的人员有：公司董事长兼总裁李海平先生；董事、副总裁孙 春光先生；董事、副总裁、财务总监兼董事会秘书谢金桃女士；独立董事何勇军 先生。 为充分尊重投资者、提升交流的针对性，现就公司 2022 年度网上业绩说明 会提前向投资者公开征集问题，广泛听取投资者的意见和建议。投资者可于 2023 年 4 月 12 日（星期三）15:00 前访问 http://ir.p5w.net/zj/，或扫描下方二维 码，进入问题征集专题页面。公司将在 2022 年度业绩说明会上，对投资者普遍 关注的问题进行回答。 欢迎广大投资者积极参与本次网上说明会。 特此公告。 （问题征集专题页面二维码） 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 天津利安隆新材料股份有限公司（以下简称"公司"）于 2023 年 4 月 7 日在 中国证监会指定的创业板信息披露网站巨潮资讯网（www.cninfo. ...

股票代码：300596 股票简称：利安隆 记录编号：2017-002 天津利安隆新材料股份有限公司 投资者调研纪要 一、 参加调研情况 1. 调研时间：2017 年 6 月 8 日上午 9:30-11:30 2. 调研地点：天津市华苑产业区榕苑路 15 号 7-A-7 公司会议室 3. 来访单位：浙商证券、国金证券 4. 接待人员：董事会秘书： 谢金桃 女士 证券事务代表：刘 佳 女士 二、 公司董事会秘书介绍公司基本情况 1、公司简介 公司是国内抗氧化剂与光稳定剂生产的龙头企业。创业团队来自于高校， 公司从 1994 年开始抗老化助剂产品的研发，多年来专注于这个领域。公司目 前具有 8200 吨抗氧化剂与 3000 吨光稳定剂的设计产能，产品应用于塑料、 橡胶、化纤、涂料以及胶黏剂等多个高分子材料领域。2003 年，公司在天津 滨海新区建立生产基地，并在天津大学设立研发中心；2008 年设立欧洲子公 司，至此开始打造自己的全球营销网络建设；2011 年在宁夏中卫建设大型生 产基地，扩大光稳定剂产能，并设立应用技术工程技术中心；2012 年设立美 国子公司、香港子公司，完善全球营销网络建设；2017 年 1 ...